Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: E9AWP6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 16 | 20 | PF00656 | 0.536 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.367 |
CLV_PCSK_FUR_1 | 71 | 75 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.367 |
DOC_PP2B_LxvP_1 | 115 | 118 | PF13499 | 0.759 |
DOC_USP7_MATH_1 | 107 | 111 | PF00917 | 0.727 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.471 |
DOC_WW_Pin1_4 | 32 | 37 | PF00397 | 0.546 |
LIG_14-3-3_CanoR_1 | 14 | 21 | PF00244 | 0.468 |
LIG_14-3-3_CanoR_1 | 77 | 82 | PF00244 | 0.675 |
LIG_APCC_ABBA_1 | 67 | 72 | PF00400 | 0.601 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.694 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.566 |
LIG_FHA_2 | 14 | 20 | PF00498 | 0.384 |
LIG_GBD_Chelix_1 | 51 | 59 | PF00786 | 0.299 |
LIG_LIR_Nem_3 | 40 | 45 | PF02991 | 0.487 |
LIG_MYND_1 | 124 | 128 | PF01753 | 0.668 |
LIG_SH2_CRK | 42 | 46 | PF00017 | 0.526 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.618 |
LIG_SH2_STAP1 | 37 | 41 | PF00017 | 0.555 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.692 |
LIG_SH3_3 | 101 | 107 | PF00018 | 0.802 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.729 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.534 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.702 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.488 |
MOD_N-GLC_2 | 29 | 31 | PF02516 | 0.666 |
MOD_NEK2_2 | 111 | 116 | PF00069 | 0.699 |
MOD_NEK2_2 | 13 | 18 | PF00069 | 0.468 |
MOD_PIKK_1 | 117 | 123 | PF00454 | 0.758 |
MOD_PKA_2 | 122 | 128 | PF00069 | 0.753 |
MOD_PKA_2 | 13 | 19 | PF00069 | 0.470 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.468 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.691 |
MOD_ProDKin_1 | 32 | 38 | PF00069 | 0.547 |
MOD_SUMO_for_1 | 82 | 85 | PF00179 | 0.691 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.535 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.633 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1P9I9 | Leptomonas seymouri | 39% | 100% |
A0A3S7WY70 | Leishmania donovani | 91% | 100% |
A4HDB4 | Leishmania braziliensis | 68% | 100% |
E9ACS7 | Leishmania major | 90% | 100% |
E9AH55 | Leishmania infantum | 92% | 100% |